MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

TESARO Company Profile (NASDAQ:TSRO)

Consensus Ratings for TESARO (NASDAQ:TSRO) (?)
Ratings Breakdown: 10 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 3.09)
Consensus Price Target: $64.00 (57.60% upside)

Analysts' Ratings History for TESARO (NASDAQ:TSRO)
Show:
DateFirmActionRatingPrice TargetActions
6/6/2016FBR & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2016Wells FargoReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2016Credit SuisseReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/6/2016MizuhoReiterated RatingBuy$67.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/6/2016WedbushReiterated RatingOutperform$72.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2016Citigroup Inc.Reiterated RatingBuy$65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/1/2016SunTrustInitiated CoverageBuy$60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2016Lake Street CapitalInitiated CoverageBuy$61.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/31/2015Raymond JamesInitiated CoverageStrong-Buy$70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2014GuggenheimInitiated CoverageBuy$46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/28/2014 forward)
Earnings History for TESARO (NASDAQ:TSRO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/5/2016Q1($1.69)($2.22)$2.48 million$0.31 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2016Q4($1.63)($1.89)$3.45 million$0.23 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2015Q315($1.52)($1.66)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($1.14)($1.51)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015Q115($1.12)($1.30)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/19/2015Q414($1.03)($1.33)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2014Q314($1.04)($1.01)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2014Q214($0.87)($1.03)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2014Q114($1.06)($1.43)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/19/2014Q413($0.78)($0.72)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013Q313($0.69)($0.88)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2013Q2 2013($0.63)($0.67)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2013Q1 2013($0.62)($0.66)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/14/2013Q4 2012($0.65)($15.41)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2012($0.55)($0.52)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/26/2012($0.55)($4.11)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for TESARO (NASDAQ:TSRO)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($1.69)($1.59)($1.64)
Q2 20162($1.69)($1.58)($1.64)
Q3 20163($1.75)($1.49)($1.61)
Q4 20163($1.75)($1.54)($1.61)
(Data provided by Zacks Investment Research)
Dividend History for TESARO (NASDAQ:TSRO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for TESARO (NASDAQ:TSRO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/10/2016Edward C EnglishVPSell7,000$40.75$285,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2016Arnold L OronskyDirectorBuy142,085$35.19$4,999,971.15View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2016Enterprise Associates 13 L NewMajor ShareholderBuy710,429$35.19$24,999,996.51View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2016Edward C EnglishVPSell7,000$43.71$305,970.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2015Edward C. EnglishVPSell17,000$50.19$853,230.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2015James O ArmitageDirectorBuy500$54.63$27,315.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2014James O ArmitageDirectorBuy1,000$38.16$38,160.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/29/2014Lawrence M AllevaDirectorBuy1,100$26.17$28,787.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/31/2013Lawrence M AllevaDirectorBuy1,449$34.33$49,744.17View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2013Peter J BarrisMajor ShareholderSell3,583$39.00$139,737.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/30/2013Lawrence M AllevaDirectorBuy1,050$28.10$29,505.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/1/2012Lawrence M AllevaDirectorBuy3,240$15.45$50,058.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/30/2012Leon O Moulder JrCEOBuy10,000$11.69$116,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for TESARO (NASDAQ:TSRO)
DateHeadline
06/27/16 03:35 PMTESARO, Inc. – Value Analysis (NASDAQ:TSRO) : June 27, 2016 -
06/26/16 05:49 PMStock Performance Focus on: Tesaro, Inc. (NASDAQ:TSRO) - Press Telegraph
06/26/16 07:49 AMOracle Investment Management INC Increased Tesaro INC (NASDAQ:TSRO) by $4.40 Million as Shares Declined - Engelwood Daily
06/26/16 07:49 AMTESARO Inc. (TSRO) Jumps 6.36% on June 23 - Equities.com
06/24/16 09:30 AMTSRO Crosses Above Key Moving Average Level
06/24/16 07:34 AMTESARO, Inc. breached its 50 day moving average in a Bullish Manner : TSRO-US : June 24, 2016 -
06/23/16 07:42 PMTESARO Inc. (TSRO) is Trading Higher on Unusual Volume for June 22 - Equities.com
06/23/16 05:49 PMTESARO Announces Rolapitant Data Presentations at the 2016 MASCC/ISOO Annual Meeting on Supportive Care in Cancer - [at noodls] - ADELAIDE, Australia, June 23, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced nine presentations of rolapitant data at the 2016 MASCC/ISOO ...
06/22/16 06:51 PMStock to Track: Tesaro, Inc. (NASDAQ:TSRO) - iStreetWire
06/22/16 06:51 PMTesaro, Inc. (NASDAQ:TSRO) Stock Momentum Hits Weakness - CML News
06/20/16 08:20 AMThis Weeks Broker Views For TESARO, Inc. (NASDAQ:TSRO) - Fiscal Standard
06/17/16 09:37 AMRecently Issued Stock Ratings For TESARO, Inc. (NASDAQ:TSRO) - Fiscal Standard
06/14/16 07:34 AMNotable Earnings Analysis: Wyndham Worldwide Corporation (NYSE:WYN), Tesaro, Inc. (NASDAQ:TSRO) - Beacon Chronicle
06/10/16 07:17 PMTESARO Inc. (TSRO) Drops 5.13% on June 09 - Equities.com
06/08/16 07:31 PMNoteworthy Wednesday Option Activity: TSRO, FB, NFLX
06/07/16 09:49 AMTrading Overview of Two Stocks: Biodel Inc. (NASDAQ:BIOD) , TESARO, Inc. (NASDAQ:TSRO) - Street Updates
06/06/16 11:08 AMTESARO : Provides Pipeline Update at ASCO Investor Briefing
06/06/16 07:53 AMTESARO, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits -
06/04/16 06:18 PMTESARO Provides Pipeline Update at ASCO Investor Briefing - [at noodls] - Rolapitant IV NDA accepted for review by FDA; PDUFA date is January 11, 2017 Sufficient PFS events reached for data analysis of both cohorts of Phase 3 niraparib NOVA trial; data expected in Q2 2016 IND ...
06/04/16 10:06 AMOracle Investment Management INC Increased Tesaro INC (NASDAQ:TSRO) by $4.40 Million as Shares Declined - CCH Daily News
06/01/16 07:40 PMTarget Price and Stock Performance Rundown for TESARO, Inc. (NASDAQ:TSRO) - HNN - Target Price and Stock Performance Rundown for TESARO, Inc. (NASDAQ:TSRO)HNNKeeping an eye on share activity using multiple views may be helpful when tracking stock performance. Equity investors have the ability to track short or long term share performance. During the latest trading session, TESARO, Inc. (NASDAQ:TSRO) shares ...and more »
06/01/16 09:56 AMHeron Therapeutics, Inc. (NASDAQ:HRTX) Went Up 11.69%: Tesaro, Inc. (NASDAQ:TSRO), VIVUS Inc. (NASDAQ ... - KC Register - Heron Therapeutics, Inc. (NASDAQ:HRTX) Went Up 11.69%: Tesaro, Inc. (NASDAQ:TSRO), VIVUS Inc. (NASDAQ ...KC RegisterTesaro, Inc. (NASDAQ:TSRO) is proud to congratulate co-founder, President and COO Dr. Mary Lynne Hedley on being named the Life Science “Entrepreneur of the Year” by the New England Venture Capital Association. The 2016 NEVY Awards celebrate ...
06/01/16 07:17 AMTESARO, Inc. breached its 50 day moving average in a Bullish Manner : TSRO-US : June 1, 2016 -
05/31/16 07:21 PMTESARO Inc. (TSRO) Jumps 5.68% on May 31 - Equities.com - TESARO Inc. (TSRO) Jumps 5.68% on May 31Equities.comTESARO Inc. (TSRO) was among the biggest gainers on the Russell 2000 for Tuesday May 31 as the stock popped 5.68% to $46.30, representing a gain of $2.49 per share. Some 778,724 shares traded hands on 7,136 trades, compared with an average ...and more »
05/31/16 09:57 AMTESARO, Inc. (NASDAQ:TSRO) 1-Year High At $66.95 - RealistInvestor.com - TESARO, Inc. (NASDAQ:TSRO) 1-Year High At $66.95RealistInvestor.comThe technical analysis of TESARO, Inc. (NASDAQ:TSRO) highlights the stock is $0.32 points away +0.73% from 50-day MA of $43.49. It is $-0.06 or -0.13% away $43.87, the stock's 200-day MA. Yesterday, the stock of TESARO, Inc. (NASDAQ:TSRO) closed at ...Jefferies Group Reiterates “Buy” Rating for TESARO Inc (TSRO)Let Me Know About ThisNext Weeks Broker Price Targets For TESARO, Inc. (NASDAQ:TSRO)Share Trading Newsall 3 news articles »
05/30/16 09:58 AMJefferies Group Reiterates “Buy” Rating for TESARO Inc (TSRO) - Let Me Know About This - Jefferies Group Reiterates “Buy” Rating for TESARO Inc (TSRO)Let Me Know About ThisTESARO Inc (NASDAQ:TSRO)'s stock had its “buy” rating reissued by stock analysts at Jefferies Group in a report released on Sunday. Other hedge funds and institutional investors have bought and sold shares of the company. Whittier Trust Co. raised its ...and more »
05/28/16 06:22 PMHold Calls Count For TESARO, Inc. (NASDAQ:TSRO) At 0 - Investor Newswire - Hold Calls Count For TESARO, Inc. (NASDAQ:TSRO) At 0Investor NewswireBuy calls count on TESARO, Inc. (NASDAQ:TSRO)'s stock stands at 0 while Sell recommendations is 0. Hold recommendation is 0. TESARO, Inc. (NASDAQ:TSRO) has a total of 8 Strong Buy recommendations and 0 Strong Sell advises as of 2016-05-27.and more »
05/27/16 09:49 AMTESARO Inc Is a Sell; Strong Momentum from Option Traders - Wall Street Hints and News - TESARO Inc Is a Sell; Strong Momentum from Option TradersWall Street Hints and NewsIn today's session TESARO Inc (TSRO) recorded an unusually high (769) contracts volume of put trades. Someone, most probably a professional was a very active buyer of the June, 2016 put, expecting serious TSRO decrease. With 769 contracts traded and ...Latest Analyst Ratings For TESARO, Inc. (NASDAQ:TSRO)Share Trading NewsAfter Today's Huge Decline, Is TESARO Inc's Near-Term Analysis Negative?The PostTesaro, Inc. (NASDAQ:TSRO) Earnings Preview: Should Investors Be Nervous?iStreetWireall 4 news articles »
05/26/16 10:02 AMLatest Analyst Ratings For TESARO, Inc. (NASDAQ:TSRO) - Share Trading News - Latest Analyst Ratings For TESARO, Inc. (NASDAQ:TSRO)Share Trading News03/14/2016 – TESARO, Inc. had its “outperform” rating reiterated by analysts at Leerink Swann. They now have a USD 69 price target on the stock. 03/01/2016 – SunTrust began new coverage on TESARO, Inc. giving the company a “buy” rating. They now ...
05/26/16 10:02 AMMarket Movers Alert: Axovant Sciences Ltd. (NYSE:AXON) , TESARO, Inc. (NASDAQ:TSRO) , - Street Updates - Market Movers Alert: Axovant Sciences Ltd. (NYSE:AXON) , TESARO, Inc. (NASDAQ:TSRO) ,Street UpdatesTESARO, Inc. (NASDAQ:TSRO) moved in red zone with decline of -0.22 points or -0.48% to $45.35. The company has a market worth of $2.08B.Total 293.87 thousand shares were exchanged in last trading session as opposed to average volume of 604.06 ...and more »
05/24/16 11:39 PMTESARO Inc. (TSRO) Jumps 6.43% on May 23 - Equities.com - TESARO Inc. (TSRO) Jumps 6.43% on May 23Equities.comTESARO Inc. (TSRO) was among the biggest gainers on the Russell 2000 for Monday May 23 as the stock popped 6.43% to $45.88, representing a gain of $2.77 per share. Some 547,610 shares traded hands on 4,681 trades, compared with an average daily ...and more »
05/23/16 11:36 PMHow Analysts Feel About TESARO Inc (NASDAQ:TSRO)? - Wall Street Hints and News - How Analysts Feel About TESARO Inc (NASDAQ:TSRO)?Wall Street Hints and NewsOut of 8 analysts covering Tesaro Inc (NASDAQ:TSRO), 7 rate it a “Buy”, 1 “Sell”, while 0 “Hold”. This means 88% are positive. Tesaro Inc has been the topic of 9 analyst reports since August 24, 2015 according to StockzIntelligence Inc. Below is a list ...and more »
05/21/16 09:56 AMCredit Suisse Initiates Coverage on TESARO Inc to Outperform - Trade Calls - Credit Suisse Initiates Coverage on TESARO Inc to OutperformTrade CallsCredit Suisse Initiates Coverage on TESARO Inc(NASDAQ:TSRO). The shares have been rated Outperform. The rating by Credit Suisse was issued on May 13, 2016. In a different note, Citigroup said it Initiates Coverage on TESARO Inc, according to a ...
05/20/16 10:15 AMStocks Movements Activity: Biodel Inc. (NASDAQ:BIOD) , TESARO, Inc. (NASDAQ:TSRO) - Street Updates - Stocks Movements Activity: Biodel Inc. (NASDAQ:BIOD) , TESARO, Inc. (NASDAQ:TSRO)Street UpdatesTESARO, Inc. (NASDAQ:TSRO) after beginning at $43.50, closed at $43.00 by cutting down -1.69% in recent trading session. Most recent session's volume of 233.81 thousand shares lower than its average volume of 598.89 thousand shares. The company ...and more »
05/19/16 11:38 PMTESARO Congratulates Dr. Mary Lynne Hedley on Being Named Life Science "Entrepreneur of the Year” by the New England Venture Capital… - WALTHAM, Mass., May 19, 2016 (GLOBE NEWSWIRE) — TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, is proud to congratulate co-founder, President and COO Dr. Mary Lynne Hedley on being named the Life Science “Entrepreneur of the ...
05/19/16 04:52 PMTESARO Congratulates Dr. Mary Lynne Hedley on Being Named Life Science "Entrepreneur of the Year" by the New England Venture Capital Association - [at noodls] - WALTHAM, Mass., May 19, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, is proud to congratulate co-founder, President and COO Dr. Mary Lynne Hedley ...
05/19/16 04:46 PMTESARO Congratulates Dr. Mary Lynne Hedley on Being Named Life Science "Entrepreneur of the Year” by the New England Venture Capital Association - [GlobeNewswire] - WALTHAM, Mass., May 19, 2016-- TESARO, Inc., an oncology-focused biopharmaceutical company, is proud to congratulate co-founder, President and COO Dr. Mary Lynne Hedley on being named the Life Science“ ...
05/19/16 09:54 AMTESARO (TSRO) Says Five Abstracts to be Presented at ASCO - Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here. TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today announced the presentation of five abstracts at the 2016 American Society of ...
05/18/16 09:58 PMETF’s with exposure to TESARO, Inc. : May 19, 2016 -
05/18/16 05:12 PMTESARO Announces Five Abstracts to be Presented at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting - [at noodls] - WALTHAM, Mass., May 18, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced the presentation of five abstracts at the 2016 American Society ...
05/18/16 04:33 PM5:33 pm Tesaro to present five abstracts at ASCO -
05/17/16 11:22 PMNea Management Company LLC Increased Tesaro INC (NASDAQ:TSRO) by $62.52 Million as Shares Declined - CCH Daily News - Nea Management Company LLC Increased Tesaro INC (NASDAQ:TSRO) by $62.52 Million as Shares DeclinedCCH Daily NewsNea Management Company Llc increased its stake in Tesaro Inc (NASDAQ:TSRO) by 16.05% based on its latest 2016Q1 regulatory filing with the SEC. Nea Management Company Llc bought 1.42M shares as the company's stock declined 9.22% while stock ...
05/17/16 07:20 AMTESARO, Inc. breached its 50 day moving average in a Bullish Manner : TSRO-US : May 17, 2016 -
05/16/16 11:44 AMBest Stocks: The Gap, Inc. (NYSE:GPS), Tesaro, Inc. (NASDAQ:TSRO), Caterpillar Inc. (NYSE:CAT), FireEye, Inc ... - KC Register - Best Stocks: The Gap, Inc. (NYSE:GPS), Tesaro, Inc. (NASDAQ:TSRO), Caterpillar Inc. (NYSE:CAT), FireEye, Inc ...KC RegisterTesaro, Inc. (NASDAQ:TSRO) reported operating results for first quarter 2016 and provided an update on the Company's development programs. TESARO reported a net loss of $90.8 million, or ($2.22) per share, for the first quarter of 2016, compared to a ...
05/16/16 11:44 AMAfter Last Week What Do Analysts Think Of TESARO, Inc. (NASDAQ:TSRO) - Share Trading News - After Last Week What Do Analysts Think Of TESARO, Inc. (NASDAQ:TSRO)Share Trading News03/28/2014 – TESARO, Inc. had its “positive” rating reiterated by analysts at Edison Group. The share price of TESARO, Inc. (NASDAQ:TSRO) was up +4.02% during the last trading session, with a day high of 43.24. 365583 shares were traded on TESARO, ...
05/16/16 11:44 AMCan TESARO Inc (NASDAQ:TSRO) Continue to Deliver Results? - Street Report - Can TESARO Inc (NASDAQ:TSRO) Continue to Deliver Results?Street Report[EDGAR] TESARO Inc (NASDAQ:TSRO)(TREND ANALYSIS) Annual Meeting of Stockholders (the “Annual Meeting”) of TESARO, Inc. (the “Company”) was held on May 11, 2016. As of March 14, 2016, the date of record for determining the stockholders ...
05/14/16 11:21 PMTesaro Inc (NASDAQ:TSRO) Receives 'Outperform' Rating From Brokers At Credit Suisse - FTSE News - FTSE NewsTesaro Inc (NASDAQ:TSRO) Receives 'Outperform' Rating From Brokers At Credit SuisseFTSE NewsTesaro Inc (NASDAQ:TSRO) Receives 'Outperform' Rating From Brokers At Credit Suisse. By Warren Smith / in US Broker Ratings / on Saturday, 14 May 2016 02:20 PM / 0 Comments. Tesaro Inc (NASDAQ:TSRO) yesterday was the subject of a new research ...Recently Changed Price Targets On TESARO, Inc. (NASDAQ:TSRO)Risers & FallersTESARO Inc (TSRO) is Initiated by Credit Suisse to OutperformMarket DigestTesaro Inc (NASDAQ:TSRO) Is Now Covered By One More Research FirmWall Street Hints and NewsFinance Dailyall 5 news articles »
05/14/16 12:04 PMTESARO, INC. Financials -
05/13/16 03:03 PMTESARO, INC. Files SEC form 8-K/A, Change in Directors or Principal Officers -
05/12/16 11:59 PMEarnings Expectations Overview: TESARO Inc (NASDAQ:TSRO) - News Oracle - Earnings Expectations Overview: TESARO Inc (NASDAQ:TSRO)News OracleLast Trade: The Company fell -2.19% and finished at $41.91. The daily volume was measured at 387,291.00 shares. The 52-week high of the share price is $66.95 and the 52-week low is $29.51. The company has a market cap of $1.91 Billion. Its latest ...
About TESARO

TESARO logoTESARO, Inc. (TESARO) is oncology-focused biopharmaceutical company. The Company acquires, in-licenses and develops oncology product candidates. The Company has in-licensed and are developing three clinical-stage product candidates, rolapitant, niraparib and TSR-011. Rolapitant is a potent and long-acting neurokinin-1, or NK-1, receptor antagonist for the prevention of chemotherapy induced nausea and vomiting (CINV); Niraparib, formerly known as MK-4827, is an orally active and potent poly (ADP-ribose) polymerase, and TSR-011 is an orally available targeted anti-cancer agent which is a potent inhibitor of both anaplastic lymphoma kinase (ALK) and tropomyosin-related kinase (TRK). The Company is also developing immuno-oncology programs by entering into a collaboration and exclusive license agreement with AnaptysBio, Inc., for the discovery and development of antibodies for several specified immuno-oncology targets.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: TSRO
  • CUSIP: 88156910
Key Metrics:
  • Previous Close: $40.61
  • 50 Day Moving Average: $43.38
  • 200 Day Moving Average: $42.97
  • P/E Ratio: N/A
  • P/E Growth: 1.84
  • Market Cap: $1.86B
  • Current Quarter EPS Consensus Estimate: $-7.09 EPS
Additional Links:
TESARO (NASDAQ:TSRO) Chart for Tuesday, June, 28, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha